↓ Skip to main content

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants

Overview of attention for article published in BMC Medicine, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
16 X users
wikipedia
2 Wikipedia pages

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
Published in
BMC Medicine, November 2012
DOI 10.1186/1741-7015-10-142
Pubmed ID
Authors

Ali A Alkhafaji, Ludovic Trinquart, Gabriel Baron, Moïse Desvarieux, Philippe Ravaud

Abstract

"Evergreening" refers to the numerous strategies whereby owners of pharmaceutical products use patent laws and minor drug modifications to extend their monopoly privileges on the drug. We aimed to evaluate the impact of evergreening through the case study of the antidepressant citalopram and its chiral switch form escitalopram by evaluating treatment efficacy and acceptability for patients, as well as health insurance costs for society.

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Denmark 1 1%
France 1 1%
Unknown 85 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Master 12 14%
Student > Bachelor 12 14%
Student > Doctoral Student 10 11%
Student > Ph. D. Student 7 8%
Other 18 20%
Unknown 14 16%
Readers by discipline Count As %
Medicine and Dentistry 31 35%
Agricultural and Biological Sciences 8 9%
Psychology 6 7%
Social Sciences 4 5%
Business, Management and Accounting 3 3%
Other 17 19%
Unknown 19 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2021.
All research outputs
#3,325,429
of 25,809,907 outputs
Outputs from BMC Medicine
#2,013
of 4,095 outputs
Outputs of similar age
#30,588
of 287,512 outputs
Outputs of similar age from BMC Medicine
#36
of 61 outputs
Altmetric has tracked 25,809,907 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,095 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.2. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,512 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.